Can the Pharmaceutical Industry Restore its Broken Image?

  • Author: Chad Walker and Dave LaMattina, Copper Pot Pictures
  • Published: 21 March 2013
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
  • Associated Suppliers: Pfizer, New York, USA

John LaMattina, former President, Pfizer Global R&D, discusses his book Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image?

Dr. John L. LaMattina is the former Senior Vice President, Pfizer Inc., and President, Pfizer Global Research and Development. In this role, Dr. LaMattina oversaw the drug discovery and development efforts of over 12,000 colleagues in the United States, Europe, and Asia directed towards new treatments for cancer, smoking cessation, rheumatoid arthritis, and AIDS.

Also of interest:

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from, please contact us first for permission and consult our permission guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH